Company: TBPH
Filing Date: 2025-12-08
Form Type: 8-K
Source: 0001104659-25-119032
Chunk: 0

Company: Theravance Biopharma, Inc.
Filing Date: 2025-12-08
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

Ampreloxetine KOL Event for Investors

On December 8, 2025, Theravance Biopharma, Inc. (the “ Company”)
is holding a virtual key opinion leader (KOL) investor event. A copy of materials that will be presented during the event is furnished
as Exhibit 99.1 to this Current Report.

2026 Annual General Meeting of Shareholders

The Company will hold its 2026 Annual General Meeting of Shareholders
on June 12, 2026, in Dublin, Ireland. Further information regarding the Annual General Meeting will be provided in the Company's proxy
materials, which will be filed with the SEC and made available to shareholders prior to the Annual General Meeting.

The information in this Current Report (including Exhibit 99.1)
is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report (including Exhibit 99.1) shall
not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended,
except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  99.1      Slide deck entitled Ampreloxetine KOL Event                                                 
   104      Cover                                                                                       

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              THERAVANCE BIOPHARMA, INC.                                                         
  Date: December 8, 2025      By:                             /s/ Aziz Sawaf                                     
                                                              Aziz Sawaf                                         
                                                              Senior Vice President and Chief Financial Officer